Induced pluripotent stem cell-derived human platelets: One step closer to the clinic

Journal of Experimental Medicine

Volumn 207, Issue 13, 2010, Pages 2781-2784

  Gekas, Christos ^a   Graf, Thomas ^b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; CARCINOGENESIS; CELL NUCLEUS; HOSPITAL; IN VITRO STUDY; ONCOGENE C MYC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ANIMALS; BLOOD PLATELETS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PLATELET TRANSFUSION; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; THROMBOCYTOPENIA;

EID: 78650343117     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102428     Document Type: Review

References (30)

1. Blum, B., O. Bar-Nur, T. Golan-Lev, and N. Benvenisty. 2009. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol. 27:281-287. doi:10.1038/nbt.1527
2. Chanprasert, S., A.E. Geddis, C. Barroga, N.E. Fox, and K. Kaushansky. 2006. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes. Cell. Signal. 18:1212-1218. doi:10.1016/j.cellsig.2005.09.010 (Pubitemid 43674046)
3. Dhara, S.K., B.A. Gerwe, A. Majumder, M.C. Dodla, N.L. Boyd, D.W. Machacek, K. Hasneen, and S.L. Stice. 2009. Genetic manipulation of neural progenitors derived from human embryonic stem cells. Tissue Eng. Part A 15:3621-3634. doi:10.1089/ten.tea.2009.0155
4. Eto, K., A.L. Leavitt, T. Nakano, and S.J. Shattil. 2003. Development and analysis of megakaryocytes from murine embryonic stem cells. Methods Enzymol. 365:142-158. doi:10.1016/S0076-6879(03)65010-X (Pubitemid 37531545)
5. Fujimoto, T.T., S. Kohata, H. Suzuki, H. Miyazaki, and K. Fujimura. 2003. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood. 102:4044-4051. doi:10.1182/blood-2003-06-1773 (Pubitemid 37486987)
6. Gaur, M., T. Kamata, S. Wang, B. Moran, S.J. Shattil, and A.D. Leavitt. 2006. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J. Thromb. Haemost. 4:436-442. doi:10.1111/j.1538-7836.2006.01744.x
7. Guo, Y., C. Niu, P. Breslin, M. Tang, S. Zhang, W. Wei, A.R. Kini, G.P. Paner, S. Alkan, S.W. Morris, et al. 2009. c-Myc-mediated control of cell fate in megakaryocyteerythrocyte progenitors. Blood. 114:2097-2106. doi:10.1182/blood-2009-01-197947
8. Jaenisch, R. 2009. Stem cells, pluripotency and nuclear reprogramming. J. Thromb. Haemost. 7:21-23. doi:10.1111/j.1538-7836.2009.03418.x
9. Junt, T., H. Schulze, Z. Chen, S. Massberg, T. Goerge, A. Krueger, D.D. Wagner, T. Graf, J.E. Italiano Jr., R.A. Shivdasani, and U.H. von Andrian. 2007. Dynamic visualization of thrombopoiesis within bone marrow. Science. 317:1767-1770. doi:10.1126/science.1146304 (Pubitemid 47461844)
10. Kaushansky, K. 2005. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115:3339-3347. doi:10.1172/JCI26674 (Pubitemid 43121817)
11. Kennedy, M., and G.M. Keller. 2003. Hematopoietic commitment of ES cells in culture. Methods Enzymol. 365:39-59. doi:10 .1016/S0076-6879(03)65003-2
12. Kerenyi, M.A., and S.H. Orkin. 2010. Networking erythropoiesis. J. Exp. Med. 207: 2543-2550.
13. Kruskall, M.S. 1997. The perils of platelet transfusions. N. Engl. J. Med. 337:1914-1915. doi:10.1056/NEJM199712253372609 (Pubitemid 28053032)
14. Lengerke, C., and G.Q. Daley. 2010. Autologous blood cell therapies from pluripotent stem cells. Blood Rev. 24:27-37. doi:10.1016/j.blre.2009.10.001
15. Mikkola, H.K., J. Klintman, H. Yang, H. Hock, T.M. Schlaeger, Y. Fujiwara, and S.H. Orkin. 2003. Haematopoietic stem cells retain longterm repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/ tal-1 gene. Nature. 421:547-551. doi:10 .1038/nature01345
16. Murphy, D.J., M.R. Junttila, L. Pouyet, A. Karnezis, K. Shchors, D.A. Bui, L. Brown-Swigart, L. Johnson, and G.I. Evan. 2008.Distinct thresholds govern Myc's biological output in vivo. Cancer Cell. 14:447-457. doi:10.1016/j.ccr.2008.10.018
17. Nakano, T., H. Kodama, and T. Honjo. 1994. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 265:1098-1101. doi:10.1126/science.8066449
18. Niu, C., J. Zhang, P. Breslin, M. Onciu, Z. Ma, and S.W. Morris. 2009. c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development. Blood. 114:2087-2096. doi:10.1182/blood-2009-01-197921
19. Olsen, A.L., D.L. Stachura, and M.J. Weiss. 2006. Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood. 107:1265-1275. doi:10.1182/blood-2005-09-3621 (Pubitemid 43242358)
20. Schuldiner, M., J. Itskovitz-Eldor, and N. Benvenisty. 2003. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells. 21:257-265. doi:10.1634/stemcells.21-3-257
21. Schulze, H., and R.A. Shivdasani. 2005. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3:1717-1724. doi:10.1111/j.1538-7836.2005.01426.x (Pubitemid 41716558)
22. Shivdasani, R.A., and S.H. Orkin. 1995. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. USA. 92:8690-8694. doi:10.1073/pnas.92.19.8690
23. Stadtfeld, M., and K. Hochedlinger. 2010. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 24:2239-2263. doi:10.1101/gad.1963910
24. Stenberg, P.E., and J. Levin. 1989. Mechanisms of platelet production. Blood Cells. 15:23-47.
25. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663-676. doi:10.1016/j.cell.2006.07.024 (Pubitemid 44233629)
26. Takayama, N., H. Nishikii, J. Usui, H. Tsukui, A. Sawaguchi, T. Hiroyama, K. Eto, and H. Nakauchi. 2008. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 111:5298-5306. doi:10.1182/blood-2007-10-117622
27. Takayama, N., S. Nishimura, S. Nakamura, T. Shimizu, R. Ohnishi, H. Endo, T. Yamaguchi, M. Otsu, K. Nishimura, M. Nakanishi, et al. 2010. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J. Exp. Med. 207:2817-2830. doi:10.1084/jem.20100844
28. Thompson, A., Y. Zhang, D. Kamen, C.W. Jackson, R.D. Cardiff, and K. Ravid. 1996. Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. J. Biol. Chem. 271:22976-22982. doi:10.1074/jbc.271.38.22976 (Pubitemid 26314727)
29. Wallace, E.L., W.H. Churchill, D.M. Surgenor, J. An, G. Cho, S. McGurk, and L. Murphy. 1995. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion. 35: 802-812. doi:10.1046/j.1537-2995. 1995.351096026360.x
30. Yoshida, Y., and S. Yamanaka. 2010. iPS cells: A source of cardiac regeneration. J. Mol. Cell. Cardiol. 10.1016/j.yjmcc.2010.20.026.